Sponsor:
Integra LifeSciences Corporation
Code:
NCT07805798
Conditions
Tissue Repair
Soft Tissue Reconstruction
Wound Management
Pressure Ulcer (PU)
Necrotizing Soft Tissue Infection
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Interventions
Urinary Bladder Matrix (UBM) Products
Brief summary:
Conditions
Tissue Repair
Soft Tissue Reconstruction
Wound Management
Pressure Ulcer (PU)
Necrotizing Soft Tissue Infection
Study ID
NCT07805798
Start date
Oct 23, 2026
Status verified date
Nov, 2026
Completion date
Dec 31, 2029
Anticipated
Primary completion date
Aug 31, 2029
Anticipated
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Not accepted
Enrollment
300 participants
Anticipated
Arms
Retrospective Cohort
Prospective Cohort
Interventions
Urinary Bladder Matrix (UBM) Products
Primary outcome measure
Central contacts
Locations
HonorHealth Research Institute
Recruiting
Scottsdale, Arizona, United States, 85258
Contacts
Principal Investigator:
Gina Golden
The University of North Carolina at Chapel Hill
Recruiting
Chapel Hill, North Carolina, United States, 27599
Contacts
Principal Investigator:
Booker King
Atrium Health
Recruiting
Charlotte, North Carolina, United States, 28207
Contacts
Principal Investigator:
Laurence Kempton
Sponsor
Integra LifeSciences Corporation
Last update posted
Nov 20, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-21. This information was provided to ClinicalTrials.gov by Integra LifeSciences Corporation on 2026-11-20. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.